RADIOLOGICAL OR NUCLEAR MEDICAL COUNTERMEASURE PRODUCT DEVELOPMENT SUPPORT (PDS)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NIAID
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N93026R00005
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN12
Additional Details
Documents4
The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), has issued a solicitation (Procurement Identifier: 75N93026R00005) seeking support for the development of radiological or nuclear medical countermeasure products. This procurement is classified under NAICS code 541715, which pertains to research and development in the physical, engineering, and life sciences, excluding nanotechnology and biotechnology. The Product Service Code is AN12, further indicating a focus on medical research and development.
The primary objective of this solicitation is to engage qualified contractors in providing comprehensive product development support for medical countermeasures targeting radiological or nuclear threats. The scope encompasses a range of activities essential to advancing these products through the development pipeline, with the intended outcome of enhancing national preparedness and response capabilities in the event of radiological or nuclear incidents. Contractors are expected to deliver robust scientific, technical, and regulatory support, facilitating the progression of candidate countermeasures toward potential approval and deployment.
Key requirements include demonstrated expertise in medical product development, particularly in the context of radiological or nuclear threats. Offerors should possess capabilities in research, preclinical and clinical development, regulatory affairs, and project management. The expected deliverables will likely involve milestone-driven progress reports, technical documentation, and tangible advancements in product readiness, although specific deliverables should be referenced in the attached solicitation documents.
The place of performance is within the United States, and the procurement is open to all qualified entities, as there are no set-aside requirements specified. This indicates that both large and small businesses may participate, provided they meet the technical and administrative criteria outlined in the solicitation.
The contracting entity is the NIH NIAID, operating under the Department of Health and Human Services. The office is responsible for overseeing the contract and ensuring alignment with federal research priorities. For further information or clarification, interested parties may contact the primary contracting officer, Karen Telphia ([email protected], 240-669-2960), or the secondary contact, Robert Corno ([email protected], 240-669-5151).
The solicitation is currently active, with a post date of July 17, 2026, and a response deadline of August 31, 2026. Amendment No. 1 has been issued to address questions from potential offerors, and relevant documents are available via the SAM.gov opportunity page (https://sam.gov/opp/049b9651d3904954aaeafb84cf91d6d6/view).
Contractors considering this opportunity should evaluate their capabilities in medical countermeasure development, regulatory compliance, and project management within the context of radiological or nuclear threats. The procurement represents a significant opportunity to contribute to national health security and advance innovative medical solutions for emergency preparedness.